A4-a6: unk.Manufacturer narrative: a review of the device labeling was completed.Iritis is identified in the labeling as known potential adverse events following icl implantation.The directions for use adequately provides surgeons instruction for icl implantation which states: as with implantation of other types of intraocular lenses, potential adverse events can include, but are not limited to infection (endophthalmitis), hypopyon, corneal endothelial damage, iol dislocation, cystoid macular edema, corneal edema, pupillary block, iritis, retinal detachment, retinal tear, transient or persistent glaucoma, vitritis, iris prolapse, secondary surgical intervention and increased visual symptoms related to the optical characteristics of the iol including halos, glare and/or double vision.The type of inflammation as well as onset and duration were not specified.Therefore, an exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.Claim # (b)(4).
|